Development
U
Vitro, S.A.B. de C.V. VITOF
$0.15 -$0.51-77.27% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Net Income 213.84% 188.35% 140.26% 116.76% 43.67%
Total Depreciation and Amortization 3.33% 0.55% 0.10% -1.49% -1.63%
Total Amortization of Deferred Charges 2.73% 2.73% 2.73% 2.73% 11.91%
Total Other Non-Cash Items -32.98% -24.63% -38.89% -87.65% -40.01%
Change in Net Operating Assets -205.62% 110.22% 158.53% 159.43% 121.25%
Cash from Operations 60.90% 119.05% 5,695.67% 1,199.48% 370.62%
Capital Expenditure -44.09% -68.92% -69.21% -59.48% -24.13%
Sale of Property, Plant, and Equipment 198.73% 48.77% 1,206.91% -11.94% -84.04%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -5,074.69% -857.50% -1,890.72% -79,824.14% 92.30%
Cash from Investing -76.30% -103.35% -116.88% -131.41% -35.84%
Total Debt Issued 175.64% 294.80% 235.78% -80.77% -51.77%
Total Debt Repaid -194.03% -196.88% -199.17% 87.21% 61.90%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -39,900.00% -39,900.00% 40.96% 40.96% 99.41%
Other Financing Activities -38.88% -138.14% -63.59% -37.50% -0.90%
Cash from Financing -191.36% 104.21% 146.16% 72.30% 80.18%
Foreign Exchange rate Adjustments -27.99% 3.20% -317.88% 45.79% -163.24%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -102.35% 246.70% 177.29% 103.36% 117.99%